Phase II study of the tolerability and efficacy of the histone deacetylase inhibitor sodium valproate [valproic acid] administered in conjunction with 5-azacitidine, theophylline and all trans-retinoic acid [tretinoin] in patients with acute myeloid leukaemia and high risk myelodysplasia
Phase of Trial: Phase II
Latest Information Update: 12 Jun 2010
At a glance
- Drugs Azacitidine; Theophylline; Tretinoin; Valproic acid
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 16 Jun 2007 New trial record.